ACTNOVA specializes in AI-driven animal behaviour analysis using its software platform, Actverse. By leveraging artificial intelligence and biosensors, the company enables researchers to perform precise, automated symptom analysis for neurodegenerative diseases such as dementia and Parkinson's. Through collaborations with institutions like MIT and the Korea Brain Research Institute, ACTNOVA aims to accelerate the biotech industry's digital transformation. Their B2B solutions support corporate and healthcare professional users in gathering critical data for medical research and diagnosis, bridging animal models with human therapeutic development.

ACTNOVA (액트노바)

ACTNOVA (액트노바)